The transcriptional response of Caenorhabditis elegans to ivermectin exposure identifies novel genes involved in the response to reduced food intake

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Laing, Steven T ^a   Ivens, Al ^b   Butler, Victoria ^c   Ravikumar, Sai P ^c   Laing, Roz ^a   Woods, Debra J ^d   Gilleard, John S ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Fios Genomics Ltd   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

^d ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; ANTIPARASITIC AGENT; FAT; FATTY ACID;

ANTHELMINTIC ACTIVITY; ARTICLE; C23G10.11 GENE; C35A5.3 GENE; C50F7.5 GENE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CYP 37B1 GENE; DOD 3 GENE; DOWN REGULATION; DRUG EXPOSURE; DRUG STRUCTURE; F18E3.11 GENE; F21C10.10 GENE; F21F8.4 GENE; F45D3.4 GENE; F46F2.3 GENE; F54F3.3 GENE; F57G8.7 GENE; F58G6.9 GENE; FATTY ACID METABOLISM; FOLT 2 GENE; FOOD INTAKE; GENE IDENTIFICATION; GENE PRODUCT; GST 10 GENE; ILYS 3 GENE; K03D3.2 GENE; LIPID METABOLISM; MOLECULAR HYBRIDIZATION; MTL 1 GENE; NONHUMAN; PHO 13 GENE; REAL TIME POLYMERASE CHAIN REACTION; SCL 2 GENE; SODH 1 GENE; SPP 23 GENE; SRM 3 GENE; T22F3.11 GENE; UGT 63 GENE; UPREGULATION; ANIMAL; DNA MICROARRAY; DRUG EFFECT; EATING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

CAENORHABDITIS ELEGANS;

ANIMALS; ANTIPARASITIC AGENTS; CAENORHABDITIS ELEGANS; EATING; FATS; FATTY ACIDS; IVERMECTIN; METABOLIC NETWORKS AND PATHWAYS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 84856824678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031367     Document Type: Article

References (52)

1. Fox LM, (2006) Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 19: 588-593 10.1097/QCO.0b013e328010774c [doi];00001432-200612000-00011 [pii].
2. Gilleard JS, (2006) Understanding anthelmintic resistance: the need for genomics and genetics. Int J Parasitol 36: 1227-1239.
3. Edward CL, Hoffmann AA, (2008) Ivermectin resistance in a horse in Australia. Vet Rec 162: 56-57 162/2/56 [pii].
4. Kaplan RM, (2004) Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol 20: 477-481.
5. Sargison ND, Jackson F, Bartley DJ, Wilson DJ, Stenhouse LJ, et al. (2007) Observations on the emergence of multiple anthelmintic resistance in sheep flocks in the south-east of Scotland. Vet Parasitol 145: 65-76 S0304-4017(06)00621-2 [pii];10.1016/j.vetpar.2006.10.024 [doi].
6. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, et al. (2004) An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 231-249 10.1179/000349804225003253 [doi].
7. Churcher TS, Pion SD, Osei-Atweneboana MY, Prichard RK, Awadzi K, et al. (2009) Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci U S A 106: 16716-16721 0906176106 [pii];10.1073/pnas.0906176106 [doi].
8. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK, (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 2021-2029 S0140-6736(07)60942-8 [pii];10.1016/S0140-6736(07)60942-8 [doi].
9. Dent JA, Davis MW, Avery L, (1997) avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J 16: 5867-5879 10.1093/emboj/16.19.5867 [doi].
10. Dent JA, Smith MM, Vassilatis DK, Avery L, (2000) The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci U S A 97: 2674-2679.
11. Etter A, Cully DF, Schaeffer JM, Liu KK, Arena JP, (1996) An amino acid substitution in the pore region of a glutamate-gated chloride channel enables the coupling of ligand binding to channel gating. J Biol Chem 271: 16035-16039.
12. Pemberton DJ, Franks CJ, Walker RJ, Holden-Dye L, (2001) Characterization of glutamate-gated chloride channels in the pharynx of wild-type and mutant Caenorhabditis elegans delineates the role of the subunit GluCl-alpha2 in the function of the native receptor. Mol Pharmacol 59: 1037-1043.
13. Vassilatis DK, Arena JP, Plasterk RH, Wilkinson HA, Schaeffer JM, et al. (1997) Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. J Biol Chem 272: 33167-33174.
14. Yates DM, Portillo V, Wolstenholme AJ, (2003) The avermectin receptors of Haemonchus contortus and Caenorhabditis elegans. Int J Parasitol 33: 1183-1193.
15. Holden-Dye L, Walker RJ, (2006) Actions of glutamate and ivermectin on the pharyngeal muscle of Ascaridia galli: a comparative study with Caenorhabditis elegans. Int J Parasitol 36: 395-402.
16. Brownlee DJ, Holden-Dye L, Walker RJ, (1997) Actions of the anthelmintic ivermectin on the pharyngeal muscle of the parasitic nematode, Ascaris suum. Parasitology 115 (Pt 5): 553-561.
17. McCavera S, Rogers AT, Yates DM, Woods DJ, Wolstenholme AJ, (2009) An ivermectin-sensitive glutamate-gated chloride channel from the parasitic nematode Haemonchus contortus. Mol Pharmacol 75: 1347-1355 mol.108.053363 [pii];10.1124/mol.108.053363 [doi].
18. Laing ST, Ivens A, Laing R, Ravikumar S, Butler V, et al. (2010) Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites. Biochem J 432: 505-514 BJ20101346 [pii];10.1042/BJ20101346 [doi].
19. Gonzalez CA, Sahagun Prieto AM, Jose Diez LM, Martinez NF, Vega MS, et al. (2009) The pharmacokinetics and metabolism of ivermectin in domestic animal species. Vet J 179: 25-37 S1090-0233(07)00249-3 [pii];10.1016/j.tvjl.2007.07.011 [doi].
20. Jones KT, Ashrafi K, (2009) Caenorhabditis elegans as an emerging model for studying the basic biology of obesity. Dis Model Mech 2: 224-229 2/5-6/224 [pii];10.1242/dmm.001933 [doi].
21. Zheng J, Greenway FL, (2011) Caenorhabditis elegans as a model for obesity research. Int J Obes (Lond) ijo201193 [pii];10.1038/ijo.2011.93 [doi].
22. Jeong PY, Kwon MS, Joo HJ, Paik YK, (2009) Molecular time-course and the metabolic basis of entry into dauer in Caenorhabditis elegans. PLoS One 4: e4162 10.1371/journal.pone.0004162 [doi].
23. Wang J, Kim SK, (2003) Global analysis of dauer gene expression in Caenorhabditis elegans. Development 130: 1621-1634.
24. Van Gilst MR, Hadjivassiliou H, Yamamoto KR, (2005) A Caenorhabditis elegans nutrient response system partially dependent on nuclear receptor NHR-49. Proc Natl Acad Sci U S A 102: 13496-13501.
25. Stiernagle T, (1999) Maintenance of C. elegans. In: Hope IA, editors. C. elegans A Practical Approach Oxford Oxford University Press pp. 51-67.
26. Johnstone IA, (1999) Molecular Biology. In: Hope IA, editors. C. elegans A Practical Approach Oxford University Press pp. 201-225.
27. Breitling R, Armengaud P, Amtmann A, Herzyk P, (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92 10.1016/j.febslet.2004.07.055 [doi];S0014579304009354 [pii].
28. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3.
29. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57 nprot.2008.211 [pii];10.1038/nprot.2008.211 [doi].
30. Jonstone IL, Barry JD, (1996) Temporal reiteration if a precise gene expression pattern during nematode development. EMBO J 15: 3633-3639.
31. Hobert O, (2002) PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. Biotechniques 32: 728-730.
32. Fire A, Harrison SW, Dixon D, (1990) A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene 93: 189-198.
33. Mello CC, Kramer JM, Stinchcomb D, Ambros V, (1991) Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10: 3959-3970.
34. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G, (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946.
35. James CE, Davey MW, (2009) Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int J Parasitol 39 (2): 213-20.
36. Custodia N, Won SJ, Novillo A, Wieland M, Li C, et al. (2001) Caenorhabditis elegans as an environmental monitor using DNA microarray analysis. Ann N Y Acad Sci 948: 32-42.
37. Menzel R, Yeo HL, Rienau S, Li S, Steinberg CE, et al. (2007) Cytochrome P450s and short-chain dehydrogenases mediate the toxicogenomic response of PCB52 in the nematode Caenorhabditis elegans. J Mol Biol 370: 1-13.
38. Reichert K, Menzel R, (2005) Expression profiling of five different xenobiotics using a Caenorhabditis elegans whole genome microarray. Chemosphere 61: 229-237.
39. Mullaney BC, Ashrafi K, (2009) C. elegans fat storage and metabolic regulation. Biochim Biophys Acta 1791: 474-478 S1388-1981(08)00241-2 [pii];10.1016/j.bbalip.2008.12.013 [doi].
40. Cui Y, McBride SJ, Boyd WA, Alper S, Freedman JH, (2007) Toxicogenomic analysis of Caenorhabditis elegans reveals novel genes and pathways involved in the resistance to cadmium toxicity. Genome Biol 8: R122.
41. Freedman JH, Slice LW, Dixon D, Fire A, Rubin CS, (1993) The novel metallothionein genes of Caenorhabditis elegans. Structural organization and inducible, cell-specific expression. J Biol Chem 268: 2554-2564.
42. Bargmann CI, (2006) Chemosensation in C. elegans. WormBook pp. 1-29 10.1895/wormbook.1.123.1 [doi].
43. Ashrafi K, (2007) Obesity and the regulation of fat metabolism. WormBook pp. 1-20 10.1895/wormbook.1.130.1 [doi].
44. Ardelli BF, Stitt LE, Tompkins JB, Prichard RK, (2009) A comparison of the effects of ivermectin and moxidectin on the nematode Caenorhabditis elegans. Vet Parasitol S0304-4017(09)00379-3 [pii];10.1016/j.vetpar.2009.06.043 [doi].
45. Kondoh M, Kamada K, Kuronaga M, Higashimoto M, Takiguchi M, et al. (2003) Antioxidant property of metallothionein in fasted mice. Toxicol Lett 143: 301-306 S0378427403001954 [pii].
46. Shinogi M, Sakaridani M, Yokoyama I, (1999) Metallothionein induction in rat liver by dietary restriction or exercise and reduction of exercise-induced hepatic lipid peroxidation. Biol Pharm Bull 22: 132-136.
47. Sogawa N, Sogawa CA, Fukuoka H, Mukubo Y, Yoneyama T, et al. (2003) The changes of hepatic metallothionein synthesis and the hepatic damage induced by starvation in mice. Methods Find Exp Clin Pharmacol 25: 601-606 778079 [pii].
48. Cousins RJ, Liuzzi JP, Lichten LA, (2006) Mammalian zinc transport, trafficking, and signals. J Biol Chem 281: 24085-24089 R600011200 [pii];10.1074/jbc.R600011200 [doi].
49. Szewczyk NJ, Udranszky IA, Kozak E, Sunga J, Kim SK, et al. (2006) Delayed development and lifespan extension as features of metabolic lifestyle alteration in C. elegans under dietary restriction. J Exp Biol 209: 4129-4139 209/20/4129 [pii];10.1242/jeb.02492 [doi].
50. Li A, Jiao X, Munier FL, Schorderet DF, Yao W, et al. (2004) Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 74: 817-826 10.1086/383228 [doi];S0002-9297(07)64351-1 [pii].
51. Nakano M, Kelly EJ, Rettie AE, (2009) Expression and Characterization of CYP4V2 as a Fatty Acid {omega}-Hydroxylase. Drug Metab Dispos dmd.109.028530 [pii];10.1124/dmd.109.028530 [doi].
52. Kulas J, Schmidt C, Rothe M, Menzel R, (2008) Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode Caenorhabditis elegans. Arch Biochem Biophys 472 (1): 65-75.